SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation
Funding will support the development of Aurase Wound Gel and progress towardfurther Phase II clinical trials of innovative wound debriding enzyme Cambridge, UK 27 March 2023 – SOLASCURE Ltd (SolasCure),…
